
Belgium-based biotech Bone Therapeutics has appointed Dr Guy Heynen as its new chief clinical and regulatory officer. Heynen is a …

Cancer Research UK (CRUK) scientists are to be given access to drug discovery facilities at AstraZeneca’s Cambridge site as part …

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …

UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS). Soliris …

Healthcare think tank the King’s Fund has called for an additional £2 billion to be injected into the NHS in …
Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …

Sharp Packaging Services that is a part of UDG Healthcare has announced that Mike O’Hara has joined the firm as …

The need for a new approach to depression that gives it equal importance to physical health was the focus of …

Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …
Novartis’ multiple myeloma treatment Farydak has been given an extended review by the FDA after its future seemed in jeopardy …

Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …

Rare-disease drug firm BioMarin has finalised its purchase of muscular disease specialist Prosensa in a deal worth over $840 million. …

Ulf Wiinberg has resigned from his chief executive post at Denmark-based pharma giant Lundbeck following a beach of its rules …

Virgo has promoted its long-standing employee Natasha Weeks (pictured) to the position of director and lead of its Consumer Health …

Ten new medicines have been recommended for approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP), among …

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

Alberto Martinez has joined Napp Pharmaceuticals in the UK as its new managing director, taking over the role from Dietmar …

The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …